The Israeli decision to be the first country in the world to grant a third vaccine against Corona to the elderly population has received much international coverage in the last day, especially in the US and UK facing a similar dilemma. Medical on the need to provide “booster injections”, and the authorities are focusing on increasing the response to vaccines and measures such as limiting crowds or mandatory corona tests for returnees from abroad, given the growing number of cases.

In Israel, the resumption of the epidemic still under control thanks to mass vaccination

– The World (@lemondefr) July 30, 2021

In Britain, the Guardian reported this morning that Prime Minister Naftali Bennett’s statement last night on the move, “makes Israel the first country to offer a third dose of Western vaccine to its residents on a large scale.” The newspaper noted that “the United States and the European Union have not approved the use of booster injections against corona — and a third fat has not yet been proven to help and if so – who needs it and at what timing.” The World Health Organization (WHO) reported in early July There is not enough evidence to justify a third dose at this stage.

To increase vaccination protection, Israel offers people over 60 years of age a third vaccination. In Portugal, meanwhile, easing of the restrictions is in sight.

– Frankfurter Allgemeine (@faznet) July 29, 2021

“Although there is no regulatory approval (for the move) in the US and Europe, and despite the lack of definite information about the effectiveness of additional injections in preventing serious illness and mortality, experts (Israelis) have concluded that promoting booster injections in older Israelis may offer the best chance of preventing infection.” , The Washington Post reported on the Israeli decision.

Israel to offer third coronavirus ‘booster’ shot for over 60s

– FRANCE 24 English (@ France24_en) July 29, 2021

The American media noted that the Israeli decision was announced in parallel with the statements of the directors of Pfizer during the shareholders’ update (as part of the presentation of the results of the second quarter). Managers, including company CEO Albert Burla, said in a conference call with investors that Pfizer is expected to apply to the FDA in mid.August to approve “booster shots” in order to increase protection against the corona virus and especially against the delta strain now spreading in many countries.

Burla told investors that “there is very good protection at first (after receiving the second dose of the vaccine), but then there is a weakening, which becomes more significant as you approach half a year after the vaccine.” He cited data coming from Israel as justifying the possibility of a third shot.

Coronavirus: Israel to give third jab to people aged over 60

– BBC News (World) (@BBCWorld) July 29, 2021

At the same time as the Israeli decision was published, Pfizer published preliminary results of an internal study that examined the effectiveness of the protection provided by the vaccine about six months after it was given, among vaccine groups and the original control group of safety trials. The study found an average 6% reduction in protection every two months after vaccination completion, to a level of 84% protection against disease with symptoms after six months. However, the data were obtained before the Delta strain appeared in the West. This strain is supposed to reduce the protection against virus infection at a much higher rate. Pfizer’s study has not yet been peer.reviewed.

It should be noted that so far, Pfizer and the German company Biontech, which developed the vaccine and signed a partnership with the American pharmaceutical giant for the benefit of trials and distribution, have mostly published results of trials in parallel. However, the results of the study published yesterday regarding efficacy after six months have not yet been published by Biontech on the company’s website. The CEO of the German company, Prof. Ohr Schahn, said in an interview with the Wall Street Journal earlier this week that the company does not want to unequivocally recommend the use or non.use of a third shot, and that “this discussion will be conducted without us – we will provide Information to governments, and they will decide. “He said that optimally, each person would in the future be able to decide personally whether or not to get vaccinated with impulse shots.

The Washington Post quoted experts criticizing Pfizer for the active approach it takes to public pressure regarding a third shot. Prof. William Schaffner, a health policy expert at Vanderbilt University, told the paper that “there are a large number of infectious disease doctors and public health professionals who are disappointed, and frankly a little angry, at Pfizer.” Pfizer is trying to recommend national health policy measures through press releases. He said, “And many of us think it’s excessively inappropriate.” He added that instead, the company could have discussed the matter with the FDA. is very”.

By Editor

Leave a Reply